Kobayashi Pharmaceutical Co Financial Overview
Kobayashi Pharmaceutical Co's market cap is currently $2.49B. The company's EPS TTM is $0.31480974; its P/E ratio is 32.51; and it has a dividend yield of 2.04%. Kobayashi Pharmaceutical Co is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
